SCHEMBL30753826

SCHEMBL30753826

Cc1cccnc1C1(F)CCN(C(=O)Nc2ccc(C(F)(C(F)(F)F)C(F)(F)F)cc2)CC1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 16/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2724826 1.00 TRPV1 (0.67) TRPV1
SCHEMBL2723773 0.92 TRPV1 (0.79) TRPV1
SCHEMBL2724894 0.90 TRPV1 (0.67) TRPV1
Trifluoroacetic Acid SCHEMBL5732367 0.88 TRPV1 (0.74) TRPV1
SCHEMBL2724621 0.87 TRPV1 (0.62) TRPV1
SCHEMBL2725222 0.85 TRPV1 (0.66) TRPV1
SCHEMBL31679061 0.85 TRPV1 (0.66) TRPV1
SCHEMBL5392806 0.85 TRPV1 (0.67) TRPV1
SCHEMBL2725244 0.84 TRPV1 (0.59) TRPV1
SCHEMBL31679069 0.84 TRPV1 (0.59) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3348267-B1 TRPV1 INHIBITOR FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY UNIV HAWAII (US) 2024-01-10 — — EP disclosed
Send feedback